Skip to main content

The Economy Wiki

[email protected]

The Economy Wiki

The Economy Wiki

Avance Clinical is an Australian CRO focused on supporting biotechnology companies through early-phase and later-stage clinical development programs. The company is especially relevant for sponsors seeking to use Australia’s clinical trial environment, regulatory pathways, and investigator networks.

Read More
The Economy Wiki

Autolus Therapeutics is a London-headquartered cell-therapy company spun out of University College London in 2014. It develops programmed autologous T-cell therapies for cancer and autoimmune diseases. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in cell & Gene Therapy Developers.

Read More
The Economy Wiki

AstraZeneca Rare Disease, built around Alexion, remains one of the leading rare disease platforms globally. The business is especially associated with complement biology and severe rare disorders affecting hematology, nephrology, neurology, and metabolic disease.

Read More
The Economy Wiki

Astellas Pharma Inc. is a Tokyo-headquartered pharmaceutical company listed on the Tokyo Stock Exchange. Astellas was established in April 2005 by merging Yamanouchi Pharmaceutical, founded in 1923, and Fujisawa Pharmaceutical, founded in 1894.

Read More
The Economy Wiki

Ascendis Pharma is an established healthcare institution whose principal relevance to this ranking lies in endocrinology and rare-disease therapeutics using prodrug technology. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biotechnology Firms.

Read More
The Economy Wiki

Arrowhead Pharmaceuticals is an established healthcare institution whose principal relevance to this ranking lies in biotechnology firms. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biotechnology Firms.

Read More
The Economy Wiki

argenx has become one of the most important rare disease and specialty immunology developers globally. Its platform is focused on antibody-based medicines for severe autoimmune diseases, including rare neuromuscular and immune-mediated conditions requiring specialist care.

Read More
The Economy Wiki

Ardena is a pharmaceutical contract development and manufacturing organization (CDMO) and bioanalytical contract research organization (CRO) whose principal relevance to this ranking lies in small-molecule and nanomedicine development and manufacturing. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biomanufacturing & CDMO Providers.

Read More
The Economy Wiki

Arcturus Therapeutics Holdings Inc. is a Nasdaq-listed RNA medicines company founded in 2013 and headquartered in San Diego, California. It develops RNA medicines and delivery technologies, including self-amplifying RNA vaccines. Its assessed scope here is vaccine and immunotherapy development.

Read More
The Economy Wiki

Arcellx is a specialist cell therapy developer focused on engineered cellular therapies for cancer, particularly multiple myeloma. Its lead program, anitocabtagene autoleucel, has become one of the most closely watched next-generation BCMA-directed CAR-T candidates.

Read More
The Economy Wiki

Apellis Pharmaceuticals is an established healthcare institution whose principal relevance to this ranking lies in complement-targeted therapies for rare hematologic and retinal diseases. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in rare Disease & Orphan Drug Developers.

Read More
The Economy Wiki

ANI Pharmaceuticals, Inc. develops, manufactures and markets branded and generic prescription medicines, including treatments for rare diseases. Its current public-company structure follows a June 2013 reverse acquisition involving BioSante and a July 2013 name change to ANI Pharmaceuticals.

Read More
The Economy Wiki

Amneal Pharmaceuticals is a global biopharmaceutical company whose principal relevance to this ranking lies in specialty and complex generic medicines. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in specialty Pharma Companies.

Read More
The Economy Wiki

Amicus Therapeutics is an established rare disease company focused on rare metabolic disorders, particularly Fabry disease and Pompe disease. The company has built its platform around precision therapy for genetically defined lysosomal storage and metabolic conditions.

Read More
The Economy Wiki

Amgen remains one of the most important biotechnology firms globally and one of the defining companies in the history of the modern biotechnology industry. The company has evolved from a pioneer of recombinant biologics into a global biopharmaceutical organization with substantial commercial scale, manufacturing depth, and pipeline breadth.

Read More
The Economy Wiki

Alnylam Pharmaceuticals is one of the most important rare disease biotechnology companies because it validated RNA interference as a therapeutic modality and built approved medicines for genetically or biologically defined diseases. Its platform is especially relevant to rare diseases where silencing a disease-causing gene can produce meaningful clinical benefit.

Read More
The Economy Wiki

Almac Group is an established healthcare institution whose principal relevance to this ranking lies in pharmaceutical development, clinical supply and commercial manufacturing. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biomanufacturing & CDMO Providers.

Read More
The Economy Wiki

Allogene Therapeutics is an established healthcare institution whose principal relevance to this ranking lies in allogeneic CAR-T cell therapy development. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in cell & Gene Therapy Developers.

Read More
The Economy Wiki

Alkermes combines drug-research employment with professional development and networking through employee resource groups. Its published framework names the Women Inspired Network and Operation Salute, with participation open to employees who wish to join. Specialty Pharma Companies Overview

Read More
The Economy Wiki

Ajinomoto Bio-Pharma Services is an Ajinomoto Group CDMO network supporting small molecules, oligonucleotides, peptides, gene therapy, proteins and bioconjugates for pharmaceutical and biotechnology customers. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 1 ranking category Overview

Read More